Unibest
← Back to patent-cliff list

Valrubicin

Tier C — Watch / trade

Valrubicin

Endo Pharmaceuticals
Originator
1998
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:TOP2

Brand:Valtaxin, Valstar

Indications (approved):Bladder cancer, 原位癌

Regional status

US
Approved
1998-09-25
EU
-
China
-
Japan
-

Synthetic routes & intermediates4 routes

Originator routes × 1Optimised (non-patent) × 3Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 2 · Total yield 181 mg
VALR-001121172-32-5VALR-0026106-41-8VALR-00364376-47-2API · Valrubicin
CodeCAS No.Intermediate
VALR-001121172-32-5(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-chloroacetyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
VALR-0026106-41-8sodium pentanoate
VALR-00364376-47-22-((2S,4S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-2-oxoethyl pentanoate hydrochloride
OptimisedRoute 2Steps 2 · Total yield 458.00 mg
VALR-00423214-92-8VALR-00526295-56-7VALR-006109-52-4API · Valrubicin
CodeCAS No.Intermediate
VALR-00423214-92-8(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
VALR-00526295-56-72,2,2-trifluoro-N-((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)acetamide
VALR-006109-52-4pentanoic acid
OptimisedRoute 3Steps 4 · Total yield 6.00 g
VALR-0026106-41-8VALR-00723541-50-6VALR-00864291-57-2VALR-00929742-67-4VALR-01080287-44-1API · Valrubicin
CodeCAS No.Intermediate
VALR-0026106-41-8sodium pentanoate
VALR-00723541-50-6(8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
VALR-00864291-57-2(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
VALR-00929742-67-4(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromoacetyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
VALR-01080287-44-12-((2S,4S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-2-oxoethyl pentanoate
OptimisedRoute 4Steps 2 · Total yield 2.19 mg
VALR-00423214-92-8VALR-00526295-56-7VALR-011638-29-9API · Valrubicin
CodeCAS No.Intermediate
VALR-00423214-92-8(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
VALR-00526295-56-72,2,2-trifluoro-N-((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)acetamide
VALR-011638-29-9pentanoyl chloride

Frequently asked questions

What are the approved indications of Valrubicin?

Approved indications include: Bladder cancer, 原位癌.

When does the Valrubicin patent expire?

No public expiry year is available for Valrubicin yet; this page updates once verified.

How many synthesis routes are recorded for Valrubicin?

4 synthesis routes are recorded; the shortest is 2 steps with 181 mg total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Valrubicin intermediates?

All intermediates in Valrubicin routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Valrubicin intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27